SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001221508-14-000021
Filing Date
2014-09-08
Accepted
2014-09-08 16:30:43
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10-K - 06-30-2014 form10k_06302014.htm 10-K 700351
2 MLPH FORM EX 31 - 06-30-2014 ex311_06302014.htm EX-31 7826
3 MLPH FORM EX 31 - 06-30-2014 ex312_06302014.htm EX-31 7728
4 MLPH FORM EX 32 - 06-30-2014 ex32_06302014.htm EX-32 3925
  Complete submission text file 0001221508-14-000021.txt   2097858

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - 06-30-2014 mlph-20140630.xml EX-101.INS 247536
6 XBRL SCHEMA FILE - 06-30-2014 mlph-20140630.xsd EX-101.SCH 11177
7 XBRL CALCULATION FILE - 06-30-2014 mlph-20140630_cal.xml EX-101.CAL 9978
8 XBRL DEFINITION FILE - 06-30-2014 mlph-20140630_def.xml EX-101.DEF 15414
9 XBRL LABEL FILE - 06-30-2014 mlph-20140630_lab.xml EX-101.LAB 106917
10 XBRL PRESENTATION FILE - 06-30-2014 mlph-20140630_pre.xml EX-101.PRE 65102
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

IRS No.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50156 | Film No.: 141091312
SIC: 2834 Pharmaceutical Preparations